はじめての方へショーケース価格
  1. 米国企業
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA

時価総額
$182.6億
PER
34.7倍
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2010年
12月31日		2011年
12月31日		2012年
12月31日		2013年
12月31日		2014年
12月31日		2015年
12月31日		2016年
12月31日		2017年
12月31日		2018年
12月31日		2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日		2023年
12月31日
Net income (loss)3,3392,7681,9101,2533,0421,597311-16,449-2,472-1,000-4,099456-2,406-615
Asset Impairment Charges1242011,0715243873611,64520,8825,621-6,5465842,4471,078
Depreciation and amortization9771,0691,7081,6421,5081,3081,5242,1121,8421,7221,5571,3301,3081,153
Net change in operating assets and liabilities253-597-414-968-290-967-1,219363,000,0001,8238962,1881,701-1,25772
Deferred Income Taxes Net And Uncertain Tax Positions-199-500-690-1,380-22623715-2,331-837-985-696-120-1,059-317
Stock-based compensation8091826495117124133155119129119124121
Other items-----736---2810016-9161
Research and development in process----------8010--
Net loss (gain) from investments and from sale of business and long-lived assets-723-18-1867641,0901918213-104-1041
Net loss (gain) from investments and from sale of business and long-lived assets-723-18-1867641,0901918213-104-1041
Other items-----736---2810016-9161
Net cash provided by (used in) operating activities4,1364,1344,5723,2375,1275,5425,2253,5072,4467481,2167981,5901,368
Beneficial interest collected in exchange for securitized trade receivables--------1,7351,4871,4051,6481,1401,477
Proceeds from Divestiture of Businesses-----------3116868
Purchases of property, plant and equipment and intangible assets-------------526
Purchases of property, plant and equipment7101,0531,1041,031929772901874651525578562548-
Proceeds from Divestiture of Businesses-----------3116868
Purchases of investments and other assets--------11985547146
Proceeds from sale of investments-----------1724-
Other investing activities-294993104305212282-11-58-24-1-5
Acquisitions of businesses, net of cash acquired4,9516,561-393633,30936,148-43----7-
Acquisitions of businesses, net of cash acquired4,9516,561-393633,30936,148-43----7-
Other investing activities-294993104305212282-11-58-24-1-5
Net cash provided by (used in) investing activities-5,455-7,601-1,134-1,147-1,450-5,565-35,7402,1641,8661,3558631,523656968
Repayment of senior notes and loans and other long term liabilities1,9727512,2133,1338392,5219993,3007,4463,9441,8716,6491,3694,152
Proceeds from Debt, Net of Issuance Costs--------4,4342,083-4,974-2,451
Proceeds from short term debt----------550700-700
Repayment of short term debt----------559700-700
Redemption of convertible debentures-----------491--
Other financing activities-5523-9-178-169-74-57-11-5-6-118-212
Net cash provided by (used in) financing activities5733,336-1,678-3,883-2,3754,80525,217-5,750-3,351-1,926-1,885-2,172-1,487-1,913
Translation adjustment on cash and cash equivalents---------142168-128-123-30
Net change in cash, cash equivalents and restricted cash--------81919320221636393
Dividend Declared To Noncontrolling Interests-------------67
Interest--------8158408469139481,078
Income Taxes Paid, Net3542766141,298675802341106420552709495543298
Interest--------8158408469139481,078
Income Taxes Paid, Net3542766141,298675802341106420552709495543298
Interest--------8158408469139481,078
Income Taxes Paid, Net3542766141,298675802341106420552709495543298
Interest--------8158408469139481,078
Income Taxes Paid, Net3542766141,298675802341106420552709495543298
Other current assets51-240-54106-3687-517658-1,437-1,416-1,473-2,271-828-1,525
Increase Decrease In Certain Current Liabilities Excluding Debt-295543-19378-614-12640-1,801-500643-4637641,9141,588
Other current assets51-240-54106-3687-517658-1,437-1,416-1,473-2,271-828-1,525
Trade receivables net of sales reserves and allowances-3627049368571076334351488-394-293-57433412
Increase Decrease In Certain Current Liabilities Excluding Debt-295543-19378-614-12640-1,801-500643-4637641,9141,588
Inventories-16-762-5113992301293721992627141380-163-147
Trade receivables net of sales reserves and allowances-3627049368571076334351488-394-293-57433412
Net Change In Items Comprising Supplemental Disclosure Of Cash Flow Information-2535974149682909671,219-363-1,823-896-2,188-1,7011,257-72
Inventories-16-762-5113992301293721992627141380-163-147
Net Change In Items Comprising Supplemental Disclosure Of Cash Flow Information-2535974149682909671,219-363-1,823-896-2,188-1,7011,257-72
Other current assets51-240-54106-3687-517658-1,437-1,416-1,473-2,271-828-1,525
Increase Decrease In Certain Current Liabilities Excluding Debt-295543-19378-614-12640-1,801-500643-4637641,9141,588
Other current assets51-240-54106-3687-517658-1,437-1,416-1,473-2,271-828-1,525
Trade receivables net of sales reserves and allowances-3627049368571076334351488-394-293-57433412
Increase Decrease In Certain Current Liabilities Excluding Debt-295543-19378-614-12640-1,801-500643-4637641,9141,588
Inventories-16-762-5113992301293721992627141380-163-147
Trade receivables net of sales reserves and allowances-3627049368571076334351488-394-293-57433412
Net Change In Items Comprising Supplemental Disclosure Of Cash Flow Information-2535974149682909671,219-363-1,823-896-2,188-1,7011,257-72
Inventories-16-762-5113992301293721992627141380-163-147
Net Change In Items Comprising Supplemental Disclosure Of Cash Flow Information-2535974149682909671,219-363-1,823-896-2,188-1,7011,257-72